Andy Norman

Andy Norman is a Global QA Director and GxP Compliance Leader currently serving as the Quality Director for sa-mRNA at CSL, where they lead the commercial launch of Kostaive®, the world's first self-amplifying mRNA vaccine. Andy has previously held significant roles at Seqirus, Astellas Pharma, and Thermo Fisher Scientific, where they strengthened global quality systems, ensured regulatory compliance, and fostered high-performing teams. They are recognized for their expertise in GMP/GDP compliance, regulatory strategy, and the development of robust quality management systems across diverse international settings. Andy is committed to driving supply chain integrity and continuous improvement initiatives throughout their career.